EUCTR2010-022641-25-NL进行中（未招募）不适用
Maraviroc Abacavir STudy – effect on Endothelial Recovery - MASTER
适应症
相关药物
试验速览
- 阶段
- 不适用
- 状态
- 进行中（未招募）
- 入组人数
- 24
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional clinical trial of medicinal product
入排标准
- 性别
- All
入选标准
- •-Age > 18 years
- •-HIV-1 infection
- •-Treatment with antiretroviral regimen containing abacavir for at least the previous 3 months
- •-Undetectable plasma HIV RNA (50 cp/ml) for at least 6 months (one ‘blip’ allowed, which is defined as a detectable plasma HIV-RNA level between 50 and 400 copies/ml, preceded and followed by undetectable (<50 copies/ml) plasma HIV-RNA measurements)
- •-CD4+ cell count > 200 cells/µL
- •-Signed informed consent
- •Are the trial subjects under 18? no
- •Number of subjects for this age range:
- •F.1.2 Adults (18-64 years) yes
- •F.1.2.1 Number of subjects for this age range
- •F.1.3 Elderly (>=65 years) yes
- •F.1.3.1 Number of subjects for this age range
排除标准
- •-Pregnancy
- •-Breastfeeding
- •-Allergy for peanuts or soya
- •-Hypersensitivity for maraviroc
- •-Treatment of underlying malignancy
- •-Acute infection in the preceding 30 days
- •-Renal insufficiency requiring hemodialysis
- •-Acute or decompensated chronic hepatitis
- •-Modification of antiretroviral regimen in the previous 3 months
研究者
相似试验
已完成
4 期
Maraviroc Abacavir STudy - effect on Endothelial Recoveryhart- en vaatziektenHIV10047438NL-OMON38245niversitair Medisch Centrum Utrecht24
Unknown
4 期
Maraviroc Abacavir STudy - Effect on Endothelial RecoveryEndothelial DysfunctionNCT01389063S.F.L. van Lelyveld24
已完成
3 期
Effect of Maraviroc on Endothelial Function in HIV-Infected PatientsHIV InfectionInflammationCardiovascular DiseaseHIV InfectionsNCT00844519University of California, San Francisco52
已完成
不适用
PARADISE in Kagoshima studyhyperlipidemia, Type 2 Diabetes MellitusJPRN-jRCTs071190049ishio Yoshihiko100
已完成
不适用
Bevacizumab and endothelium dependent vasodilatiohigh blood pressure10057166HypertensionNL-OMON32503niversitair Medisch Centrum Sint Radboud24